Acute myeloid leukaemia (AML)

AML is a type of blood cancer that starts from young white blood cells in the bone marrow. Find out how common it is and who might get it.

Symptoms of AML can include tiredness, breathlessness, high temperature, frequent infections and bruising or bleeding easily.

Most people start by seeing their GP if they have symptoms of blood cancer such as leukaemia. Other people may go to accident and emergency (A and E) depending on their symptoms.

Survival for acute myeloid leukaemia (AML) depends on many factors. These include your age and genetic changes in the AML cells.

Chemotherapy is the main treatment for acute myeloid leukaemia (AML). Other treatments include a stem cell transplant and targeted cancer drugs.

Doctors divide AML into different groups (subtypes). They also divide AML into risk groups based on genetic changes and other factors.

Researchers are looking at ways to improve treatment for AML. This includes different drug combinations, reducing side effects and preventing AML from coming back.

Support is available during and after acute myeloid leukaemia (AML) treatment.

We don’t know what causes most cases of acute myeloid leukaemia. But there are some factors that may increase your risk of developing it.